
about 5 years ago // Sponsored by USP
Delays of 10-20 years have occurred with the rollout of previous vaccines in Africa. How could stronger cross-continental regulatory collaboration reduce that timeline for COVID-19 vaccines? USP explains.
about 6 years ago // Sponsored by Chemonics
With potential new HIV treatment options on the horizon, how can a successful transition between regimens be secured at a country and local level? Drawing on its role in a recent transition to TLD, Chemonics shares its advice.